/PRNewswire/ American Skin Association has announced the names of the two awardees receiving the coveted research grant under the ASA Milstein Research.
BOSTON — An increase in immune checkpoint proteins was observed in metastatic melanoma patients treated with topical diphencyprone, according to a study presented at the American Academy of Dermatology Annual Meeting.“Diphencyprone, or DCPD for short, has been used for many years to treat various dermatologic conditions including alopecia areata and warts, but more recently it’s